Jagsonpal Pharmaceuticals Limited announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced total revenue was INR 567.662 million compared to INR 422.497 million a year ago. Net income was INR 40.088 million compared to INR 20.291 million a year ago. Basic earnings per share from continuing operations was INR 1.53 compared to INR 0.77 a year ago. Diluted earnings per share from continuing operations was INR 4.53 compared to INR 0.77 a year ago. For the half year, total revenue was INR 892.028 million compared to INR 881.549 million a year ago. Net income was INR 65.291 million compared to INR 40.328 million a year ago. Basic earnings per share from continuing operations was INR 2.49 compared to INR 1.54 a year ago.